Gilead Sciences, Inc (NASDAQ: GILD) has agreed to pay $97 million to settle allegations that it illegally paid for Medicare co-pays for its own pulmonary arterial hypertension drug Letairis through a charitable entity.What Happened: The Foster City, California-based drugmaker allegedly used a conduit foundation named Caring Voice Coalition (CVC) even though it was prohibited from doing so under the Anti-Kickback Statute, according to a statement issued by the U.S. Department of Justice.”Gilead used CVC to cover the patients’ co-pays in order to induce those patients’ purchases of Letairis,” the Justice Department claimed. “Gilead knew that the prices it set …read more
Source:: Yahoo Finance
